Lemonade (LMND)
(Delayed Data from NYSE)
$18.71 USD
+1.17 (6.67%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $18.67 -0.04 (-0.21%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.71 USD
+1.17 (6.67%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $18.67 -0.04 (-0.21%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Zacks News
ADTRAN (ADTN) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
ADTRAN (ADTN) beats second-quarter earnings estimates on healthy demand trends, end-to-end fiber broadband solutions and improved customer diversification.
Knowles' (KN) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Knowles (KN) beats second-quarter earnings estimates but misses on revenues due to weak demand for MEMS microphones.
Wall Street Analysts Believe Lemonade (LMND) Could Rally 46%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 46.4% upside potential for Lemonade (LMND). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
MetLife (MET) to Announce Q2 Earnings: Here's What to Expect?
by Zacks Equity Research
MetLife's (MET) second-quarter results are likely to reflect increased premiums and improved profits in Latin America.
Lemonade (LMND) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Kemper (KMPR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Kemper (KMPR) delivered earnings and revenue surprises of -26.53% and 0.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Lemonade (LMND) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Lemonade (LMND) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unum Group (UNM) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Unum Group (UNM) Q2 results are likely to reflect higher persistency, higher sales and favorable incidence.
What's in the Cards for Prudential (PRU) in Q2 Earnings?
by Zacks Equity Research
Prudential's (PRU) Q2 results are likely to benefit from business growth and favorable underwriting results in both group life and disability, offset by lower net investment spread results and market depreciation.
Will Assurant (AIZ) Pull Off a Surprise This Earnings Season?
by Zacks Equity Research
Assurant's (AIZ) second-quarter results are likely to reflect organic growth from strong U.S. sales, an increase in global mobile devices serviced and continued growth from renters insurance.
How Investors Can Grab Better Returns for Finance Using the Zacks ESP Screener
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Lemonade and MasTec have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Lemonade and MasTec have been highlighted as Zacks Bull and Bear of the Day.
Bull of the Day: Lemonade (LMND)
by Kevin Cook
50-60% revenue growth toward $300 million has analysts raising estimates for this Insur-Tech small cap
Wall Street Analysts Believe Lemonade (LMND) Could Rally 61%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Lemonade (LMND) points to a 60.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Lemonade (LMND) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Lemonade (LMND) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Lemonade (LMND) Q1 Earnings, Revenues Beat, Premiums Up Y/Y
by Zacks Equity Research
Lemonade (LMND) Q1 results reflect gross earned premiums improved, driven by an increase in-force premium earned offset by higher expense.
Lemonade (LMND) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 15.38% and 2.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Fidelity National (FNF) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Fidelity National (FNF) Q1 earnings are likely to have benefited from higher direct premium, agency premiums as well as escrow, title-related and other fees.
What's in the Cards for Lemonade (LMND) in Q1 Earnings?
by Zacks Equity Research
Lemonade's (LMND) Q1 results are likely to reflect a shift of business mix toward products with higher average policy values, higher customer base and improved premium per customer.
SelectQuote (SLQT) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
SelectQuote (SLQT) delivered earnings and revenue surprises of 78.95% and 5.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Kemper (KMPR) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Kemper (KMPR) delivered earnings and revenue surprises of -42.42% and 2.01%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Lemonade (LMND) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Lemonade (LMND) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unum Group (UNM) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Unum Group's (UNM) Q1 earnings are likely to have benefited from persistency, growth in the dental and vision product line and growth in the in-force block.
Lemonade (LMND) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Lemonade (LMND) closed at $20.56 in the latest trading session, marking a -1.44% move from the prior day.
Lemonade (LMND) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Lemonade (LMND) closed the most recent trading day at $24.25, moving +1.04% from the previous trading session.